Literature DB >> 30667541

Data-independent acquisition-based quantitative proteomic analysis reveals differences in host immune response of peripheral blood mononuclear cells to sepsis.

Yiqing Tong1, Xin Ku2, Chunrong Wu1, Jianjun Liu1, Chunhui Yang1, Wenzhi Tang3, Wei Yan2, Jianguo Tang1.   

Abstract

This study was aimed to uncover proteins that are differentially expressed in sepsis. Data-independent acquisition (DIA) was used for analysis to identify differentially expressed proteins in peripheral blood mononuclear cells (PBMCs) of patients. A total of 24 non-septic intensive care unit (ICU) patients, 11 septic shock patients and 27 patients diagnosed with sepsis were recruited for the mass spectrometry (MS) discovery. PBMCs were isolated from routine blood samples and digested into peptides. A DIA workflow was developed using a quadrupole-Orbitrap liquid chromatography LC-MS system, and mass spectra peaks were extracted by Skyline software. Orthogonal partial least-squares discriminant analysis (OPLS-DA) and partial least-squares discriminant analysis (PLS-DA) were applied to distinguish the patient groups at the level of fragment ion and peptide. Differentially expressed proteins in the patient groups were verified by enzyme-linked immunosorbent assay (ELISA). Receiver-operating characteristic (ROC) curves were used to evaluate the protein expression. A total of 1062 fragment ions and 122 proteins were identified in the MS-DIA analysis conducted by Skyline software. Using gene ontology clustering analysis, we discovered that 51 of the 122 identified proteins were associated with biological processes, including carbon metabolism, biosynthesis of antibiotics, platelet activation, bacterial invasion of epithelial cells and complement, and coagulation cascades. Among them, five proteins (high-mobility group box1 [HMGB1], matrix metalloproteinase 8 [MMP8], neutrophil gelatinase-associated lipocalin [NGAL], lactotransferrin [LTF] and grancalcin [GCA]) were identified by ELISA as closely related to the development of sepsis. The ROC curves displayed good sensitivity and specificity.
© 2019 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Keywords:  data-independent acquisition; peripheral blood mononuclear cells; proteomics; sepsis

Mesh:

Substances:

Year:  2019        PMID: 30667541     DOI: 10.1111/sji.12748

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients.

Authors:  M Martin-Fernandez; L M Vaquero-Roncero; R Almansa; E Gómez-Sánchez; S Martín; E Tamayo; M C Esteban-Velasco; P Ruiz-Granado; M Aragón; D Calvo; J Rico-Feijoo; A Ortega; E Gómez-Pesquera; M Lorenzo-López; J López; C Doncel; C González-Sanchez; D Álvarez; E Zarca; A Ríos-Llorente; A Diaz-Alvarez; E Sanchez-Barrado; D Andaluz-Ojeda; J M Calvo-Vecino; L Muñoz-Bellvís; J I Gomez-Herreras; C Abad-Molina; J F Bermejo-Martin; C Aldecoa; M Heredia-Rodríguez
Journal:  BJS Open       Date:  2020-02-19

2.  Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus.

Authors:  Xvwen Zhai; Min Feng; Hui Guo; Zhaojun Liang; Yanlin Wang; Yan Qin; Yanyao Wu; Xiangcong Zhao; Chong Gao; Jing Luo
Journal:  Front Cell Infect Microbiol       Date:  2021-03-01       Impact factor: 5.293

3.  Abnormal Proteomics Profile of Plasma Reveals the Immunological Pathogenesis of Severe Aplastic Anemia.

Authors:  Weiwei Qi; Yu Zhang; Wenhao Yang; Chunyan Liu; Huaquan Wang; Rong Fu; Zonghong Shao
Journal:  Dis Markers       Date:  2022-05-06       Impact factor: 3.434

4.  LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis.

Authors:  Meiyan Luo; Qian Zhang; Yingchun Hu; Changfeng Sun; Yunjian Sheng; Cunliang Deng
Journal:  Infect Drug Resist       Date:  2021-07-24       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.